ZA987723B - Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases - Google Patents

Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases

Info

Publication number
ZA987723B
ZA987723B ZA987723A ZA987723A ZA987723B ZA 987723 B ZA987723 B ZA 987723B ZA 987723 A ZA987723 A ZA 987723A ZA 987723 A ZA987723 A ZA 987723A ZA 987723 B ZA987723 B ZA 987723B
Authority
ZA
South Africa
Prior art keywords
medicament
inhibitor
sodium
treatment
cardiovascular diseases
Prior art date
Application number
ZA987723A
Other languages
English (en)
Inventor
Wolfgang Scholtz
Udo Albus
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ZA987723B publication Critical patent/ZA987723B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ZA987723A 1997-08-27 1998-08-26 Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases ZA987723B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737224A DE19737224A1 (de) 1997-08-27 1997-08-27 Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen

Publications (1)

Publication Number Publication Date
ZA987723B true ZA987723B (en) 1999-03-01

Family

ID=7840257

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA987723A ZA987723B (en) 1997-08-27 1998-08-26 Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases

Country Status (23)

Country Link
US (1) US6348476B1 (fr)
EP (1) EP0937464B1 (fr)
JP (1) JP4436940B2 (fr)
KR (1) KR19990023904A (fr)
CN (1) CN1172665C (fr)
AR (1) AR017513A1 (fr)
AU (1) AU738598B2 (fr)
BR (1) BR9803233A (fr)
CA (1) CA2245776A1 (fr)
CZ (1) CZ270998A3 (fr)
DE (1) DE19737224A1 (fr)
HK (1) HK1018211A1 (fr)
HR (1) HRP980464A2 (fr)
HU (1) HUP9801924A3 (fr)
IL (1) IL125913A0 (fr)
NO (1) NO320264B1 (fr)
NZ (1) NZ331533A (fr)
PL (1) PL195566B1 (fr)
RU (1) RU2227751C2 (fr)
SK (1) SK116798A3 (fr)
TR (1) TR199801661A2 (fr)
TW (1) TW589175B (fr)
ZA (1) ZA987723B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945302A1 (de) * 1999-09-22 2001-03-29 Merck Patent Gmbh Biphenylderivate als NHE-3-Inhibitoren
US6423705B1 (en) 2001-01-25 2002-07-23 Pfizer Inc. Combination therapy
IL147696A0 (en) * 2001-01-25 2002-08-14 Pfizer Prod Inc Combination therapy
RU2004126702A (ru) * 2002-02-04 2005-04-20 АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) Комбинированный препарат на основе ингибитора натрий-водородного обмена карипорида с ингибиторами ангиотензинконвертирующего фермента для предотвращения сердечной недостаточности и других, обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни
US6844361B2 (en) 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
US7629493B2 (en) * 2003-05-06 2009-12-08 Merck Patent Gmbh Process for the crystallisation of guandinium salts
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
DE10356717A1 (de) * 2003-12-02 2005-07-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten
US7531569B2 (en) * 2003-12-02 2009-05-12 Sanofi-Aventis Deutschland Gmbh Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
CA2586547A1 (fr) * 2004-11-05 2006-05-11 King Pharmaceuticals Research & Development, Inc. Particules de ramipril stabilisees et individuellement enrobees, compositions et methodes associees
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
WO2018002673A1 (fr) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii
EP3960165A1 (fr) * 2020-08-25 2022-03-02 Fondation EspeRare Inhibiteurs de nhe-1 pour le traitement des infections à coronavirus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE158278T1 (de) 1992-02-15 1997-10-15 Hoechst Ag Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
EP0589336B1 (fr) * 1992-09-22 1997-01-08 Hoechst Aktiengesellschaft Benzoylguanidines, leur procédé de préparation et leur utilisation comme agents antiarrhythmiques
DE4328869A1 (de) 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE19741635A1 (de) * 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Also Published As

Publication number Publication date
CA2245776A1 (fr) 1999-02-27
RU2227751C2 (ru) 2004-04-27
PL195566B1 (pl) 2007-10-31
US6348476B1 (en) 2002-02-19
HU9801924D0 (en) 1998-10-28
IL125913A0 (en) 1999-04-11
JPH11139990A (ja) 1999-05-25
EP0937464A3 (fr) 2003-09-24
HUP9801924A3 (en) 2004-11-29
TR199801661A2 (xx) 1999-03-22
CZ270998A3 (cs) 1999-03-17
NO983926L (no) 1999-03-01
PL328251A1 (en) 1999-03-01
AU8190898A (en) 1999-03-11
AR017513A1 (es) 2001-09-12
CN1209316A (zh) 1999-03-03
NZ331533A (en) 2000-04-28
KR19990023904A (ko) 1999-03-25
BR9803233A (pt) 2000-05-02
NO320264B1 (no) 2005-11-14
HK1018211A1 (en) 1999-12-17
EP0937464A2 (fr) 1999-08-25
TW589175B (en) 2004-06-01
DE19737224A1 (de) 1999-03-18
EP0937464B1 (fr) 2012-07-11
JP4436940B2 (ja) 2010-03-24
HUP9801924A2 (hu) 2000-02-28
SK116798A3 (en) 1999-03-12
CN1172665C (zh) 2004-10-27
AU738598B2 (en) 2001-09-20
HRP980464A2 (en) 1999-06-30
NO983926D0 (no) 1998-08-26

Similar Documents

Publication Publication Date Title
HUP0201686A3 (en) Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
ZA987723B (en) Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases
PL312064A1 (en) Soft gelatinous form of pharmaceutical dose
IL121650A0 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a non steroidal antiinflammatory drug
ZA9610935B (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
IL121652A0 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
AP9801173A0 (en) Rapidly releasing and taste-making pharmaceutical dosage
EP1009377A4 (fr) Utilisations medicales des pyruvates
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
HUP9802795A3 (en) Pharmaceutical compositions containing beta-adrenergic agent and anorectic agent for the treatment of corpulence
GB9418064D0 (en) Medicament administration inhaler
IL120558A0 (en) New hormonal medicaments and their use for the correction of oestrogenic deficiencies
FR2761887B1 (fr) Medicament visant a la prevention multifactorielle des maladies cardiovasculaires
IL112745A0 (en) Formulations for orally administered pharmaceutical agents
HUP0003679A3 (en) Use of pkc inhibitors for the preparation of pharmaceutical compositions treating cardiovascular diseases
PT879054E (pt) Aplicação de derivados de pirrolidina na preparação de medicamentos para o tratamento do abuso de drogas
HUP9801686A3 (en) Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseases
PL325509A1 (en) Therapeutic agent for oral administration
IL126068A0 (en) The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart
EP0925791A4 (fr) Agent preventif et/ou therapeutique pour les maladies des reins
GB2313309B (en) Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine
GB2341319B (en) Use of compounds in the preparation of a medicament for the therapeutic treatment of a wasting syndrome
ZA951418B (en) 2-(4-methoxyphenoxy)-3-pyridineamine its pharmaceutical compositions and therapeutic use
SI1183015T1 (en) Multilayered tablet for administration of a fixed combination of tramadol and diclofenac